National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.

J. Tarasuk, Jingxuan Zhang, A. LeMyre, F. Cholette, M. Bryson, D. Paquette
{"title":"National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.","authors":"J. Tarasuk, Jingxuan Zhang, A. LeMyre, F. Cholette, M. Bryson, D. Paquette","doi":"10.14745/ccdr.v46i05a07","DOIUrl":null,"url":null,"abstract":"Background\nThe Tracks survey of people who inject drugs (PWID) collected data in 14 sentinel sites across Canada (2017-2019).\n\n\nObjective\nTo describe the prevalence of human immunodeficiency virus (HIV) and hepatitis C and associated risk behaviours and to examine trends over time.\n\n\nMethods\nInformation regarding socio-demographics, social determinants of health, use of prevention services and testing, drug use, risk behaviours, and HIV and hepatitis C testing, care and treatment was collected through interviewer-administered questionnaires. Biological samples were tested for HIV, hepatitis C antibodies and hepatitis C ribonucleic acid (RNA). Descriptive statistics were calculated and trends over time were assessed.\n\n\nResults\nOf the 2,383 participants, 65.6% were cisgender male, 42.2% were Indigenous, 48.0% completed some high school or less, 62.6% lived in unstable housing and 75.7% had ever been incarcerated. Average age was 40.1 years. The majority experienced stigma and discrimination (88.7%) and physical, sexual and/or emotional abuse in childhood (85.0%) or with a sexual partner (75.9%). The majority reported use of a needle/syringe distribution program (90.1%) and tested for HIV (90.5%) and hepatitis C (90.9%).Among participants who had ever had sex, the majority (59.2%) reported inconsistent condom use during vaginal and/or anal sex with a casual sex partner. Prevalence of HIV was 10.3% (82.9% were aware of infection status) and many (36.9%) were hepatitis C RNA-positive (50.1% were aware of infection status).Most surveillance indicators remained relatively stable from Phase 1 to Phase 4. Changes were found in substances used, and improvements were noted related to HIV and hepatitis C prevalence and care cascade indicators.\n\n\nConclusion\nMany PWID in Canada were living in unstable housing and experienced high levels of stigma and discrimination. Prevalence of HIV and hepatitis C was high in some areas. These findings contribute to the evidence base used to inform targeted prevention and control measures.","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":"15 1","pages":"138-148"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v46i05a07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Background The Tracks survey of people who inject drugs (PWID) collected data in 14 sentinel sites across Canada (2017-2019). Objective To describe the prevalence of human immunodeficiency virus (HIV) and hepatitis C and associated risk behaviours and to examine trends over time. Methods Information regarding socio-demographics, social determinants of health, use of prevention services and testing, drug use, risk behaviours, and HIV and hepatitis C testing, care and treatment was collected through interviewer-administered questionnaires. Biological samples were tested for HIV, hepatitis C antibodies and hepatitis C ribonucleic acid (RNA). Descriptive statistics were calculated and trends over time were assessed. Results Of the 2,383 participants, 65.6% were cisgender male, 42.2% were Indigenous, 48.0% completed some high school or less, 62.6% lived in unstable housing and 75.7% had ever been incarcerated. Average age was 40.1 years. The majority experienced stigma and discrimination (88.7%) and physical, sexual and/or emotional abuse in childhood (85.0%) or with a sexual partner (75.9%). The majority reported use of a needle/syringe distribution program (90.1%) and tested for HIV (90.5%) and hepatitis C (90.9%).Among participants who had ever had sex, the majority (59.2%) reported inconsistent condom use during vaginal and/or anal sex with a casual sex partner. Prevalence of HIV was 10.3% (82.9% were aware of infection status) and many (36.9%) were hepatitis C RNA-positive (50.1% were aware of infection status).Most surveillance indicators remained relatively stable from Phase 1 to Phase 4. Changes were found in substances used, and improvements were noted related to HIV and hepatitis C prevalence and care cascade indicators. Conclusion Many PWID in Canada were living in unstable housing and experienced high levels of stigma and discrimination. Prevalence of HIV and hepatitis C was high in some areas. These findings contribute to the evidence base used to inform targeted prevention and control measures.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
track对加拿大注射吸毒者的调查结果,第4阶段,2017-2019。
2017-2019年,注射吸毒者(PWID)的追踪调查收集了加拿大14个哨点的数据。目的描述人类免疫缺陷病毒(HIV)和丙型肝炎的流行情况以及相关的危险行为,并研究其长期趋势。方法通过问卷调查收集社会人口统计学、健康的社会决定因素、预防服务和检测的使用、药物使用、危险行为、艾滋病毒和丙型肝炎检测、护理和治疗等信息。对生物样本进行HIV、丙型肝炎抗体和丙型肝炎核糖核酸(RNA)检测。计算描述性统计数据并评估随时间变化的趋势。结果在2383名参与者中,65.6%为顺性别男性,42.2%为原住民,48.0%高中及以下学历,62.6%居住在不稳定的住房中,75.7%曾被监禁。平均年龄为40.1岁。大多数人在童年时期(85.0%)或与性伴侣(75.9%)经历过耻辱和歧视(88.7%)和身体、性和/或精神虐待(85.0%)。大多数人报告使用了针头/注射器分发方案(90.1%),并进行了艾滋病毒(90.5%)和丙型肝炎(90.9%)检测。在曾经发生过性行为的参与者中,大多数(59.2%)报告在与随意性伴侣进行阴道和/或肛交时不一致地使用安全套。HIV患病率为10.3%(82.9%知晓感染状况),丙型肝炎rna阳性(50.1%知晓感染状况)较多(36.9%)。从第一阶段到第四阶段,大多数监测指标保持相对稳定。发现所使用的物质发生了变化,并注意到与艾滋病毒和丙型肝炎患病率和护理级联指标相关的改善。结论加拿大的许多PWID患者居住在不稳定的住房中,受到高度的污名和歧视。在一些地区,艾滋病毒和丙型肝炎的患病率很高。这些发现有助于为有针对性的预防和控制措施提供证据基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations. Summary of the mpox outbreak in Canada, April 28-December 31, 2022. Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis. Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison. Differences in sensationalism in international news media reporting of COVID-19: An exploratory analysis using the Global Public Health Intelligence Network (GPHIN) system.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1